Copyright: -
Published on: 2 January 2021
Publication: New Straits Times
Contact us for more information on License Usage.
Additional fees
Historical Fee
RM50.00
(Includes 8% SST) RM158.00
Items linked to this document

Hong Seng expanding healthcare ops with Neogenix, eMedAsia deals

2 January 2021

KUALA LUMPUR: Hong Seng Consolidated Bhd, through wholly-owned HS Bio Supplies Sdn Bhd, has signed share sale agreements to buy Neogenix Laboratoire Sdn Bhd and eMedAsia Sdn Bhd.

Cypark’s net profit falls 45.2pc to RM21.3m

2 January 2021

KUALA LUMPUR: Cypark Resources Bhd’s net profit in the fourth quarter ended Oct 31 last year fell 45.2 per cent to RM21.3 million from RM38.87 million in the same quarter the previous year.

CYPARK WASTE TO ENERGY
18240874